stella
beta
A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma — Stella
Home
/
Hepatocellular Carcinoma
/
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma trials
Trial locations
(1 site)
China
Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian